Prescribing Patterns of Proton Pump Inhibitors in Germany: A Retrospective Study Including 472 146 Patients
This study highlights that discrepancies exist between clinical guidelines and real-life prescribing practices of PPIs in Germany. Particular attention should be given to the incidence of patients being prescribed high-dose or long-duration PPI with mild indications. These findings are particularly apt considering the publication (March 2023) of new guidelines on the "management of gastroesophageal reflux disease and eosinophilic esophagitis," by the DGVS.PMID:38142444 | DOI:10.1177/21501319231221002
Source: Primary Care - Category: Primary Care Authors: Kate Plehhova Monika Haering Joshua Wray Cathal Coyle Eduardo Ib áñez Karel Kostev Source Type: research
More News: Acid Reflux | Databases & Libraries | Esomeprazole | Gastritis | Gastroenterology | Gastroesophageal Reflux Disease | GERD | Germany Health | Heartburn | Lansoprazole | Nexium | Omeprazole | Prevacid | Prilosec | Primary Care | Proton Pump Inhibitors PPIs | Study